Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Papp

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Psychiatry|January 1, 1990
Chronic anxiety: deciding the length of treatmentJ M Gorman, L A Papp
The American Journal of Psychiatry|October 1, 1990
Suicidal preoccupation during fluoxetine treatmentL A Papp, J M Gorman
Depression and Anxiety|December 1, 2000
Efficacy of venlafaxine in mixed depression-anxiety statesJ M Gorman, L A Papp
Lancet (London, England)|February 10, 1990
Urine pH in panic: a possible screening deviceL A Papp, J M Gorman
The American Journal of Psychiatry|June 1, 1988
Sex differences in panic disorderL A Papp, J M Gorman
Journal of Affective Disorders|February 13, 2001
How study of respiratory physiology aided our understanding of abnormal brain function in panic disorderS Sinha, L A Papp, J M Gorman
Psychiatry Research|July 1, 1988
Arterial epinephrine levels in panic disorderL A Papp, J Martinez, J M Gorman
The American Journal of Psychiatry|May 1, 1990
Acetazolamide as a control for CO2-induced panicD F Klein, L A Papp, J M Gorman
The American Journal of Psychiatry|August 1, 1993
Carbon dioxide hypersensitivity, hyperventilation, and panic disorderL A Papp, D F Klein, J M Gorman
The Journal of Clinical Psychiatry|February 1, 1994
Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patientsL Tiffon, J D Coplan, L A Papp, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Psychiatry|January 1, 1990
Chronic anxiety: deciding the length of treatmentJ M Gorman, L A Papp
The American Journal of Psychiatry|October 1, 1990
Suicidal preoccupation during fluoxetine treatmentL A Papp, J M Gorman
Depression and Anxiety|December 1, 2000
Efficacy of venlafaxine in mixed depression-anxiety statesJ M Gorman, L A Papp
Lancet (London, England)|February 10, 1990
Urine pH in panic: a possible screening deviceL A Papp, J M Gorman
The American Journal of Psychiatry|June 1, 1988
Sex differences in panic disorderL A Papp, J M Gorman
Journal of Affective Disorders|February 13, 2001
How study of respiratory physiology aided our understanding of abnormal brain function in panic disorderS Sinha, L A Papp, J M Gorman
Psychiatry Research|July 1, 1988
Arterial epinephrine levels in panic disorderL A Papp, J Martinez, J M Gorman
The American Journal of Psychiatry|May 1, 1990
Acetazolamide as a control for CO2-induced panicD F Klein, L A Papp, J M Gorman
The American Journal of Psychiatry|August 1, 1993
Carbon dioxide hypersensitivity, hyperventilation, and panic disorderL A Papp, D F Klein, J M Gorman
The Journal of Clinical Psychiatry|February 1, 1994
Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patientsL Tiffon, J D Coplan, L A Papp, et al.
Pageof 6